Mads Laustsen
Directeur/Bestuurslid bij NANOFORM FINLAND OYJ
Oorsprong van het eerstegraads netwerk van Mads Laustsen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.
21
| Extinct | Chemicals: Specialty | 21 |
| Public Company | Biotechnology | 13 | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.
5
| Extinct | Pharmaceuticals: Major | 5 |
Bactolife A/S
 Bactolife A/S BiotechnologyHealth Technology Bactolife A/S is a Danish industrial biotech company that specializes in developing biological solutions to strengthen the gut microbiome and combat antimicrobial resistance. Bactolife is based in Kongens Lyngby, Denmark and was founded in 2017 by Andreas Hougaard Laustsen, Per Falholt, Mads Laustsen, David Kauffmann, and Sandra Wingaard Thrane. The company has approximately 40 employees and uses its proprietary binding protein technology to select and produce binding proteins that act on toxins without targeting growth or killing bacteria directly. Bactolife is developing and marketing ingredients for various groups, including mothers and children, the elderly, immunodeficient individuals, travelers, deployed individuals, and animal health. The company has proof of concept for its technology, including its most advanced animal health product, ablacto+, which stabilizes the gut of piglets and reduces the severity of post-weaning diarrhea. Mads Laustsen has been the CEO since 2017.
5
| Holding Company | Biotechnology | 5 |
VenomAid Diagnostics ApS
 VenomAid Diagnostics ApS Medical/Nursing ServicesHealth Services VenomAid Diagnostics ApS provides diagnostic test services for snake bites. The company is based in Kongens Lyngby, Denmark. The Danish company was founded by Cecilie Knudsen, Søren H. Dam, Jonas A. Jürgensen, Andreas Hougaard Laustsen. Jonas A. Jürgensen has been the CEO since incorporation.
3
| Holding Company | Medical/Nursing Services | 3 |
Synklino ApS
 Synklino ApS Medical/Nursing ServicesHealth Services Synklino ApS is a Danish biotech company that focuses on developing innovative therapies against virus infections. The company's first-in-class drug candidate, Syn002, targets cytomegalovirus infection in transplantation patients and aims to change the current antiviral treatment paradigm. Synklino is owned by renowned Nordic funds and institutional investors, including Eir Ventures, the Danish Growth Fund, and PKA, as well as approximately 70 private shareholders. The company is a spinout from the University of Copenhagen and the Technical University of Denmark and is incubated at the BioInnovation Institute in its prestigious Creation House program.
1
| Holding Company | Medical/Nursing Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mads Laustsen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| HNI CORPORATION | Office Equipment/Supplies | Director/Board Member | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact Human Resources Officer Chief Tech/Sci/R&D Officer Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Chief Executive Officer | |
Genomatica, Inc.
 Genomatica, Inc. BiotechnologyHealth Technology Genomatica, Inc. designs and develops biotechnology products. It offers metabolic engineering for renewable production of commodity chemicals. The company was founded by Bernhard O. Palsson and Christophe H. Schilling in 1998 and is headquartered in San Diego, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| CORBION N.V. | Food: Specialty/Candy | Director/Board Member Director/Board Member | |
| KØBENHAVNS LUFTHAVNE A/S | Other Transportation | Chairman | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | President Public Communications Contact Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| BIOPORTO A/S | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree | |
EEP Advisers Ltd.
 EEP Advisers Ltd. Investment ManagersFinance EEP Advisers Ltd. (EEP) is a private equity firm founded in 1999 by Hans Blomberg and David Kauffmann. The firm is headquartered in London. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Investment Managers | Director/Board Member Private Equity Investor | |
DADES A/S
 DADES A/S Real Estate DevelopmentFinance DADES A/S provides real estate investment services. It owns and operates shopping centers, office buildings, and residential properties. The company was founded by Ejnar Danielsen in 1937 and is headquartered in Kongens Lyngby, Denmark. | Real Estate Development | Chairman | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Aarhus | College/University | Undergraduate Degree Director/Board Member Doctorate Degree Graduate Degree | |
| Technical University of Denmark | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Hovione Farmaciência SA
 Hovione Farmaciência SA Pharmaceuticals: MajorHealth Technology Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| University of Copenhagen | College/University | Chairman Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin | |
| University of Helsinki | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree | |
COWI A/S
 COWI A/S Engineering & ConstructionIndustrial Services COWI A/S provides engineering and consulting services. It specializes in economics, management and planning; water and environment; railways, metros, roads, and airports; buildings; geographical information; bridge, tunnel; and marine structures. The company was founded by Christen Ostenfeld in 1930 and is headquartered in Kongens Lyngby, Denmark. | Engineering & Construction | Chairman Chairman | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
| University of Lisbon | College/University | Undergraduate Degree Undergraduate Degree | |
TMJ MidCo ApS
 TMJ MidCo ApS Financial ConglomeratesFinance Part of McKesson Europe AG, TMJ MidCo ApS is an investment holding Danish company. The company is based in Taastrup, Denmark. The company was founded in 2005. Thomas Marstrand has been the CEO of the company since 2022. | Financial Conglomerates | Chairman | |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Executive Officer Private Equity Investor | |
COWI Holding A/S
 COWI Holding A/S Engineering & ConstructionIndustrial Services COWI Holding A/S engages in providing engineering and consulting services. The firm through its subsidiaries provides consultancy services within the fields of engineering, environmental science and economics. Its subsidiaries offer consultancy services for infrastructure such as bridges, tunnels, marine structures, airports, and mapping. The company was founded in 2010 and is headquartered in Kongens Lyngby, Denmark. | Engineering & Construction | Chairman Chairman | |
| Steno Diabetes Center A/S | Chairman Chairman | ||
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chairman | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
New Xellia Group A/S
 New Xellia Group A/S Financial ConglomeratesFinance New Xellia Group A/S operates as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chairman Director/Board Member | |
| CURASIGHT A/S | Medical Specialties | Director/Board Member Chairman | |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Bionova Capital SCR SA
 Bionova Capital SCR SA Investment ManagersFinance Bionova Capital SCR SA. (Bionova Capital) is a venture capital firm founded in 2015. It was previously known as Hovione Capital. The firm is headquartered in Lisbon, Portugal. | Investment Managers | Director of Finance/CFO Director/Board Member | |
F-Star Beta Ltd.
 F-Star Beta Ltd. BiotechnologyHealth Technology F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Chairman | |
| Lactobio ApS | Director/Board Member | ||
Efd Investment A/S
 Efd Investment A/S Financial ConglomeratesFinance Efd Investment A/S is an investment holding Danish company founded in 2015. The private company is based in Charlottenlund, Denmark. The company functions as a holding company for investments. | Financial Conglomerates | Chairman | |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer |
Statistieken
Internationaal
| Denemarken | 24 |
| Verenigde Staten | 8 |
| Verenigd Koninkrijk | 7 |
| Portugal | 4 |
| Oostenrijk | 3 |
Sectoraal
| Health Technology | 20 |
| Finance | 11 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Industrial Services | 3 |
Operationeel
| Director/Board Member | 274 |
| Corporate Officer/Principal | 106 |
| Chairman | 90 |
| Independent Dir/Board Member | 61 |
| Chief Executive Officer | 52 |
Sterkste connecties
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Søren Lemonius | 39 |
| Martin Edwards | 38 |
| Walther Thygesen | 25 |
| Steen Riisgaard | 24 |
| Ronald Eastman | 24 |
| Lise Kingo | 23 |
| Cynthia Flowers | 22 |
| Peter Helt Jacobsen Haahr | 21 |
| Per Falholt | 18 |
| Kurt Anker Nielsen | 18 |
| Kirsten Drejer | 18 |
| John Sørensen Haurum | 17 |
| Miguel Laustsen de Oliveira Barreiros Calado | 17 |
| Gregory D. Phelps | 17 |
- Beurs
- Insiders
- Mads Laustsen
- Bedrijfsconnecties
